ES407730A1 - Un procedimiento para preparar nuevas pirimidinonas. - Google Patents
Un procedimiento para preparar nuevas pirimidinonas.Info
- Publication number
- ES407730A1 ES407730A1 ES407730A ES407730A ES407730A1 ES 407730 A1 ES407730 A1 ES 407730A1 ES 407730 A ES407730 A ES 407730A ES 407730 A ES407730 A ES 407730A ES 407730 A1 ES407730 A1 ES 407730A1
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- hydrogen
- formula
- see formula
- pyrimidinones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19400671A | 1971-10-29 | 1971-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES407730A1 true ES407730A1 (es) | 1976-01-16 |
Family
ID=22715935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES407730A Expired ES407730A1 (es) | 1971-10-29 | 1972-10-18 | Un procedimiento para preparar nuevas pirimidinonas. |
| ES436624A Expired ES436624A1 (es) | 1971-10-29 | 1975-04-15 | Un procedimiento para preparar nuevas hidroxipirmidinas. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES436624A Expired ES436624A1 (es) | 1971-10-29 | 1975-04-15 | Un procedimiento para preparar nuevas hidroxipirmidinas. |
Country Status (25)
| Country | Link |
|---|---|
| JP (2) | JPS5337870B2 (sv) |
| AR (2) | AR198798A1 (sv) |
| AT (2) | AT320656B (sv) |
| AU (1) | AU467600B2 (sv) |
| BE (1) | BE790125A (sv) |
| CA (1) | CA980778A (sv) |
| CH (2) | CH549579A (sv) |
| DE (3) | DE2264374C3 (sv) |
| DK (1) | DK131465B (sv) |
| EG (1) | EG11013A (sv) |
| ES (2) | ES407730A1 (sv) |
| FI (1) | FI55503C (sv) |
| FR (1) | FR2157865B1 (sv) |
| GB (2) | GB1377308A (sv) |
| IE (1) | IE37043B1 (sv) |
| IL (2) | IL40458A (sv) |
| LU (1) | LU66304A1 (sv) |
| NL (1) | NL166470C (sv) |
| NO (1) | NO136574C (sv) |
| PH (2) | PH10129A (sv) |
| PL (2) | PL84634B1 (sv) |
| SE (2) | SE393376B (sv) |
| SU (2) | SU498908A3 (sv) |
| YU (2) | YU35125B (sv) |
| ZA (1) | ZA727362B (sv) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55151912U (sv) * | 1979-04-17 | 1980-11-01 | ||
| JPS5752409Y2 (sv) * | 1979-11-05 | 1982-11-15 | ||
| DE3222914A1 (de) * | 1982-06-18 | 1983-12-22 | Beiersdorf Ag, 2000 Hamburg | Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| JPH0655686B2 (ja) * | 1988-08-30 | 1994-07-27 | 宇部興産株式会社 | ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法 |
| US7776870B2 (en) | 2005-08-22 | 2010-08-17 | Melior Pharmaceuticals I, Inc. | Methods for modulating Lyn kinase activity and treating related disorders |
| US8552184B2 (en) | 2008-07-03 | 2013-10-08 | Melior Pharmaceuticals I, Inc. | Compounds and methods for treating disorders related to glucose metabolism |
| US10786503B2 (en) | 2017-04-10 | 2020-09-29 | Melior Pharmaceuticals I, Inc. | Treatment of adipocytes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2913462A (en) * | 1959-11-17 | Eahl h | ||
| GB951431A (en) * | 1959-03-17 | 1964-03-04 | Wellcome Found | Pyrimidine derivatives and the manufacture thereof |
-
0
- BE BE790125D patent/BE790125A/xx not_active IP Right Cessation
-
1972
- 1972-02-18 GB GB774872A patent/GB1377308A/en not_active Expired
- 1972-02-18 GB GB5005373A patent/GB1377720A/en not_active Expired
- 1972-09-25 SE SE7212358A patent/SE393376B/sv unknown
- 1972-09-28 IL IL40458A patent/IL40458A/en unknown
- 1972-09-28 AU AU47228/72A patent/AU467600B2/en not_active Expired
- 1972-10-02 PH PH13959A patent/PH10129A/en unknown
- 1972-10-05 DE DE2264374A patent/DE2264374C3/de not_active Expired
- 1972-10-05 DE DE2248741A patent/DE2248741C3/de not_active Expired
- 1972-10-05 DE DE2264657A patent/DE2264657C2/de not_active Expired
- 1972-10-06 AT AT00933/74A patent/AT320656B/de not_active IP Right Cessation
- 1972-10-06 AT AT858972A patent/AT321308B/de not_active IP Right Cessation
- 1972-10-12 YU YU2551/72A patent/YU35125B/xx unknown
- 1972-10-12 FI FI2825/72A patent/FI55503C/fi active
- 1972-10-13 NO NO3686/72A patent/NO136574C/no unknown
- 1972-10-13 SU SU1839308A patent/SU498908A3/ru active
- 1972-10-16 NL NL7213959.A patent/NL166470C/xx not_active IP Right Cessation
- 1972-10-16 IE IE1398/72A patent/IE37043B1/xx unknown
- 1972-10-16 PL PL1972158297A patent/PL84634B1/pl unknown
- 1972-10-16 ZA ZA727362A patent/ZA727362B/xx unknown
- 1972-10-16 LU LU66304A patent/LU66304A1/xx unknown
- 1972-10-16 PL PL1972174103A patent/PL89852B1/pl unknown
- 1972-10-16 CA CA153,956A patent/CA980778A/en not_active Expired
- 1972-10-16 DK DK510072AA patent/DK131465B/da not_active IP Right Cessation
- 1972-10-16 CH CH165674A patent/CH549579A/fr not_active IP Right Cessation
- 1972-10-16 JP JP10279972A patent/JPS5337870B2/ja not_active Expired
- 1972-10-16 CH CH1507872A patent/CH555832A/fr not_active IP Right Cessation
- 1972-10-16 FR FR7236560A patent/FR2157865B1/fr not_active Expired
- 1972-10-18 ES ES407730A patent/ES407730A1/es not_active Expired
- 1972-10-19 EG EG431/72A patent/EG11013A/xx active
- 1972-10-23 AR AR244763A patent/AR198798A1/es active
-
1973
- 1973-07-12 AR AR249053A patent/AR196263A1/es active
-
1974
- 1974-03-26 SU SU2008490A patent/SU505362A3/ru active
-
1975
- 1975-04-15 ES ES436624A patent/ES436624A1/es not_active Expired
- 1975-05-06 SE SE7505279A patent/SE397090B/sv unknown
- 1975-11-21 PH PH17784A patent/PH11594A/en unknown
-
1976
- 1976-01-05 IL IL48790A patent/IL48790A/en unknown
-
1978
- 1978-02-08 JP JP1336078A patent/JPS53116386A/ja active Granted
-
1979
- 1979-04-25 YU YU991/79A patent/YU36295B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES391299A1 (es) | Procedimiento para la preparacion de n-alil 2 - arilamino -imidazolinas (2) sustituidas. | |
| ES405983A1 (es) | Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados. | |
| ES407730A1 (es) | Un procedimiento para preparar nuevas pirimidinonas. | |
| ES405982A1 (es) | Procedimiento para la preparacion de 4-aza-bencimidazoles. | |
| ES411341A1 (es) | Procedimiento para la preparacion de compuestos heteroci- clicos sustituidos por un radical guanidinilideno. | |
| ES397370A1 (es) | Procedimiento para la preparacion de un compuesto tranqui- lizante. | |
| ES389360A1 (es) | Procedimiento para la preparacion de acidos ariloxi- o bienariltioalcanicos. | |
| ES421068A1 (es) | Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas. | |
| ES450380A1 (es) | Procedimiento para preparar derivados de acido indanacetico. | |
| ES418113A1 (es) | Un procedimiento para la preparacion de nuevas piperacino- pirimidinas. | |
| ES423958A1 (es) | Procedimiento para la obtencion de derivados del indol. | |
| ES427454A1 (es) | Procedimiento para la preparacion de 2-carbalcoxi-amino- bencimidazol-5-(6)-fenileteres. | |
| ES425216A1 (es) | Procedimiento para la preparacion de nuevas triazolo - 1,5 - benzodiazepinas sustituidas. | |
| ES419739A1 (es) | Procedimiento para la preparacion de 2-arilamino-imidazoli-nas (2) sustituidas. | |
| ES448390A1 (es) | Procedimiento para la preparacion de isoriazolilureas susti-tuidas. | |
| ES410313A2 (es) | Procedimiento para lapreparacion de 6,7-dimetoxi-quinazoli-nonas. | |
| ES419019A1 (es) | Procedimiento para la preparacion de compuestos polici- clicos. | |
| ES430587A1 (es) | Procedimiento para la preparacion de 4 amino-3,5-dihalogeno-feniletanolaminas. | |
| ES424486A1 (es) | Un procedimiento para preparar tiadiazolilimidazolidinonas. | |
| ES401342A1 (es) | Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales. | |
| ES451375A1 (es) | Procedimiento para la preparacion de 2-4 diamino-5-bencil-pirimidinas. | |
| ES411737A1 (es) | Procedimiento para la preparacion de compuestos heteroci- clicos binucleares. | |
| ES390275A1 (es) | Un procedimiento para la preparacion de 1,2-dialquil (infe-rior) pirrolidinas. | |
| ES428624A1 (es) | Procedimiento para la preparacion de derivados de la pirimi-dina. | |
| ES356092A1 (es) | Un procedimiento para la preparacion de derivados de acido 2-naftilacetico 5-sustituidos. |